Content Library

Toxicologic Pathology Forum: Adverse vs Nonadverse NFD in IT-Delivered Oligonucleotide Studies

Expert guidance on classifying adverse vs. nonadverse nerve fiber degeneration in intrathecal oligonucleotide nonclinical toxicity studies.

The Communication Disconnect in Device Development: A New Perspective from StageBio

Explore how early integration of toxicologic pathology can improve medical device safety, reduce miscommunication, and strengthen regulatory outcomes in device development.

Bridging the Gap: Integrating Toxicologic Pathology Best Practices into Medical Device Evaluation

Learn how integrating toxicologic pathology best practices into medical device evaluation can improve biological assessment, strengthen regulatory outcomes, and reduce study risk.

A highly standardized and reproducible porcine model for the evaluation of wound healing

StageBio Director of Digital and Quantitative Pathology Thomas Lemarchand, DMV, DESV-AP, PhD, DECVP, recently co-authored a study that successfully demonstrated the effectiveness of a highly standardized porcine model for assessing dermal and epidermal wound healing.

GLP & Non-GLP: What's the Difference?

Good Laboratory Practices (GLP) refers to a system where non-clinical health and safety studies are carried out, planned, monitored, recorded, archived and reported.

Upcoming Events

EuroTox 2026

Date: Sept 13-16
Location: Vienna, Austria

ESGCT 2026

Date: Oct 27-30
Location: Hamburg, Germany

Stay up to date on upcoming events by signing up for our quarterly newsletter!

Learn more about StageBio’s COVID-19 response